Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	94351
Country	China

Received	2024-03-16 14:13
Peer-Review Started	2024-03-16 14:13
To Make the First Decision
Return for Revision	2024-06-04 04:50
Revised	2024-06-12 06:34
Second Decision	2024-06-21 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-21 05:50
Articles in Press	2024-06-21 05:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-06-25 08:30
Publish the Manuscript Online	2024-09-18 11:53

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Personalized treatment of perihilar cholangiocarcinoma based on tumor genetic and molecular characteristics
Manuscript Source	Invited Manuscript
All Author List	He-Nan Tang, Ming-Wei Wang, Xue-Song Liu and Yan Jiao
ORCID	Author(s) ORCID Number He-Nan Tang http://orcid.org/0000-0002-7769-6435 Yan Jiao http://orcid.org/0000-0001-6914-7949
Funding Agency and Grant Number
Corresponding Author	Yan Jiao, MD, PhD, Surgeon, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, No. 71 Xinmin Street, Changchun 130021, Jilin Province, China. lagelangri1@126.com
Key Words	Perihilar cholangiocarcinoma; Molecular characteristics; Tumor genetic; Personalized; Treatment
Core Tip	Genetic and molecular profiling of perihilar cholangiocarcinoma (pCCA) has identified a number of key abnormalities that drive tumor growth and spread. pCCA is still hard to treat, and individualized anticancer treatment is required, which is supposed to be according to the genetic and molecular features. The personalized treatment should be explored to improve outcomes for patients with this challenging disease.
Publish Date	2024-09-18 11:53
Citation	<p>Tang HN, Wang MW, Liu XS, Jiao Y. Personalized treatment of perihilar cholangiocarcinoma based on tumor genetic and molecular characteristics. <i>World J Gastrointest Surg</i> 2024; 16(9): 2769-2773</p>
URL	https://www.wjgnet.com/1948-9366/full/v16/i9/2769.htm
DOI	https://dx.doi.org/10.4240/wjgs.v16.i9.2769

Full Article (PDF)	WJGS-16-2769-with-cover.pdf
Manuscript File	94351_Auto_Edited-YJP.docx
Answering Reviewers	94351-answering-reviewers.pdf
Audio Core Tip	94351-audio.mp3
Conflict-of-Interest Disclosure Form	94351-conflict-of-interest-statement.pdf
Copyright License Agreement	94351-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94351-non-native-speakers.pdf
Peer-review Report	94351-peer-reviews.pdf
Scientific Misconduct Check	94351-scientific-misconduct-check.png
Scientific Editor Work List	94351-scientific-editor-work-list.pdf
CrossCheck Report	94351-crosscheck-report.pdf